β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Growth
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Growth | Gross Profit Growth | EBIT Growth | Operating Income Growth | Net Income Growth | EPS Growth | EPS Diluted Growth | Weighted Average Shares Growth | Weighted Average Shares Diluted Growth | Dividends per Share Growth | Operating Cash Flow Growth | Free Cash Flow Growth | Ten Y Revenue Growth Per Share | Five Y Revenue Growth Per Share | Three Y Revenue Growth Per Share | Ten Y Operating CF Growth Per Share | Five Y Operating CF Growth Per Share | Three Y Operating CF Growth Per Share | Ten Y Net Income Growth Per Share | Five Y Net Income Growth Per Share | Three Y Net Income Growth Per Share | Ten Y Shareholders Equity Growth Per Share | Five Y Shareholders Equity Growth Per Share | Three Y Shareholders Equity Growth Per Share | Ten Y Dividend per Share Growth Per Share | Five Y Dividend per Share Growth Per Share | Three Y Dividend per Share Growth Per Share | Receivables Growth | Inventory Growth | Asset Growth | Book Value per Share Growth | Debt Growth | R&D Expense Growth | SGA Expenses Growth |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | -0.0191 | -0.1157 | -0.1569 | -0.1569 | -0.1697 | -0.1551 | -0.151 | -0.0174 | -0.0212 | 0.0553 | -0.1585 | -0.3331 | 0.9769 | 0.594 | 0.0413 | 2.4696 | 0.8037 | 0.1402 | 2.7649 | 1.0664 | -0.2412 | 1.7224 | 0.7283 | 0.1705 | 0.9725 | 0.3283 | 0.1787 | 0.0791 | -0.1327 | -0.0485 | -0.0523 | -0.0216 | 0.0102 | -0.0421 |
2023-12 | 0.0217 | -0.0061 | -0.079 | -0.079 | 0.0128 | 0.0139 | 0.0194 | -0.0013 | -0.0065 | 0.055 | 0.0725 | -0.0566 | 1.0192 | 0.7083 | 0.3665 | 2.2987 | 1.676 | 0.6345 | 3.9498 | 1.8526 | 0.7048 | 1.9774 | 1.0522 | 0.5451 | 0.9923 | 0.3466 | 0.1786 | 0.009 | 0.0479 | 0.0588 | 0.0744 | -0.0279 | 0.1692 | 0.1151 |
2022-12 | 0.0195 | -0.0336 | -0.0243 | -0.0243 | -0.1146 | -0.1146 | -0.1084 | 0.0 | -0.0065 | 0.0587 | 0.2397 | 0.329 | 1.0835 | 0.7931 | 0.5606 | 2.531 | 1.7312 | 0.961 | 5.6356 | 2.8617 | 1.411 | 2.3666 | 1.0836 | 0.6974 | 0.9857 | 0.3743 | 0.1931 | 0.0376 | 0.0961 | 0.0914 | 0.1496 | -0.0227 | 0.1079 | -0.1265 |
2021-12 | 0.3189 | 0.5313 | 0.8488 | 0.8488 | 0.9116 | 0.9017 | 0.8971 | 0.0067 | 0.0065 | 0.0552 | 0.2359 | 0.109 | 1.1514 | 0.8486 | 0.6376 | 3.0478 | 1.6224 | 1.0099 | 6.9408 | 3.5404 | 2.1771 | 2.2305 | 1.0589 | 0.6613 | 0.9953 | 0.4062 | 0.2056 | 0.2691 | 0.1777 | 0.1861 | 0.2508 | -0.0012 | 0.1257 | 0.2013 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more financial growth data for West Pharmaceutical Services!
Sign up for free or log inπ Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!